INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $285,000 | +52.4% | 88,100 | 0.0% | 0.00% | – |
| Q4 2020 | $187,000 | +81.6% | 88,100 | 0.0% | 0.00% | – |
| Q3 2020 | $103,000 | +28.8% | 88,100 | 0.0% | 0.00% | – |
| Q2 2020 | $80,000 | +8.1% | 88,100 | 0.0% | 0.00% | – |
| Q1 2020 | $74,000 | -12.9% | 88,100 | 0.0% | 0.00% | – |
| Q4 2019 | $85,000 | -6.6% | 88,100 | 0.0% | 0.00% | – |
| Q3 2019 | $91,000 | -42.8% | 88,100 | 0.0% | 0.00% | – |
| Q2 2019 | $159,000 | -4.2% | 88,100 | 0.0% | 0.00% | – |
| Q1 2019 | $166,000 | +59.6% | 88,100 | 0.0% | 0.00% | – |
| Q4 2018 | $104,000 | -56.5% | 88,100 | 0.0% | 0.00% | – |
| Q3 2018 | $239,000 | +42.3% | 88,100 | 0.0% | 0.00% | – |
| Q2 2018 | $168,000 | -9.2% | 88,100 | 0.0% | 0.00% | – |
| Q1 2018 | $185,000 | +3.4% | 88,100 | 0.0% | 0.00% | – |
| Q4 2017 | $179,000 | +53.0% | 88,100 | 0.0% | 0.00% | – |
| Q3 2017 | $117,000 | -15.2% | 88,100 | 0.0% | 0.00% | – |
| Q2 2017 | $138,000 | -51.6% | 88,100 | 0.0% | 0.00% | – |
| Q1 2017 | $285,000 | +129.8% | 88,100 | -4.1% | 0.00% | – |
| Q4 2016 | $124,000 | -13.3% | 91,900 | 0.0% | 0.00% | – |
| Q3 2016 | $143,000 | +9.2% | 91,900 | -6.5% | 0.00% | – |
| Q2 2016 | $131,000 | -75.5% | 98,300 | -3.1% | 0.00% | -100.0% |
| Q1 2016 | $534,000 | -36.8% | 101,400 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $845,000 | -7.0% | 107,600 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $909,000 | -22.8% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,178,000 | -30.9% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,704,000 | 0.0% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,704,000 | +18.0% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,444,000 | +5.3% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,371,000 | +20.8% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,135,000 | -17.6% | 107,600 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,378,000 | -28.0% | 107,600 | -1.9% | 0.00% | -50.0% |
| Q3 2013 | $1,914,000 | +28.5% | 109,700 | +19.8% | 0.00% | +33.3% |
| Q2 2013 | $1,489,000 | – | 91,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |